CVS names Joyner as CEO under investor pressure, withdraws profit forecast
CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including activist Glenview Capital pressured the company to improve its stagnant share price.
CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.
The shift in management is not surprising as the company looks to level set its operations and strategically position itself ...
America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...
ABC 7 Los Angeles on MSN4h
CVS workers across 7 SoCal stores strike for better pay, affordable healthcareSome CVS workers in Southern California are protesting over what they call unfair labor practices, and more employees are ...
It's a tumultuous time at industry giant CVS Health, and on Friday the company revealed a shakeup at the top that now has ...
CVS Health shares fell Friday as the pharmacy and healthcare company announced an immediate change at CEO, with company ...
Retail pharmacy giants Walgreens Boots Alliance ( WBA 6.24%) and CVS Health ( CVS 0.03%) have been struggling in recent years ...
CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback